Context

Elos Medtech entered into an agreement to acquire 100% of Klingel Medical Group from IK Partners and its management team. The strategic rationale for the deal is to create a market-leading European MedTech CDMO with significantly enhanced R&D capabilities and a broader technological offering. The acquisition expands Elos Medtech's industrial presence in the DACH region by adding eight specialized manufacturing sites in Germany and Switzerland. Strategically, the combination aims to unlock cross-selling opportunities and provides Klingel with increased visibility and distribution channels in the U.S. market. This milestone consolidation allows the combined entity to leverage a global footprint to drive operational improvements and cater to the unique needs of international OEM customers in the medical device sector.

Target

Founded in 1922, Klingel Medical Group is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in high-precision metal products for the medical technology sector. The company's business model focuses on the end-to-end production of complex components and medical devices, utilizing advanced CNC milling, turning, and cleanroom assembly. Its value proposition is anchored in extensive R&D capabilities and specialized technological expertise required for surgical instruments and implants. Strategically, the firm operates as a mission-critical partner for global medical OEMs, maintaining eight production facilities across Germany and Switzerland with approximately 900 employees. By providing a "one-stop-shop" service for the orthopedics, spine, and dental markets, the organization has established a dominant footprint in the DACH region.